NPM1 and acute myeloid leukemia: In a cohort of 1570 AML patients, NPM1-mut cases displayed a favorable prognosis, with a hazard ratio of death of 0.7 and a median OS of nearly 6 years compared to about 2 years in those with NPM1-WT AML [1].